Invented super blood immunity to dioxins

Recently, US scientists have revealed that 'super blood' will be injected into American soldiers so they can fight dioxins themselves when participating in the war.

Whitehead Institute scientist Harvey Lodish said: 'We want to make red blood cells more valuable and functional than simply delivering oxygen.'

Scientists have tested this technology on red blood cells of mice and humans to show that it is capable of treating or diagnosing diseases.

It is known that human red blood cells can circulate in the body for up to four months. This has led scientists to envision the possibility that these cells will carry antibodies to neutralize the toxins. It also keeps these antibodies longer in the body.

Researchers also say red blood cells are the optimal means for potential therapeutic applications thanks to their abundance in the body and their long lifespan.

Furthermore, the most important thing is that in the production of red blood cells, the original blood cells that later become adolescent red blood cells will have to expel their nuclei and AND. When there are no nuclei, mature red blood cells will lack genetic material or signs of previous genetic changes. That leads to the formation of tumors or any other side effects.

Exploiting this feature of red blood cells, Lodish and his laboratory staff have produced genes that encode specific changes in cell surface proteins at the early stages of formation. red blood cells.

Lodish believes that this is an applied study with great potential in removing bad cholesterol in the blood , removing blood clots in treating stroke or deep vein thrombosis, providing anti-inflammatory antibodies to reduce Reduce chronic inflammation.

This research has attracted the attention of the US military and the Office of Advanced Defense Project Research (DARPA). It is known that DARPA has decided to support the Whitehead Institute's research for the benefit of developing effective treatments or vaccines against biological weapons. And in the future, American soldiers will inherit the ' super blood ' research results.